EnLiven Therapeutics
EnLiven Therapeutics is a registered legal entity registered in United States under 20201617684, and its current status with Colorado Secretary of State is active. The company was incorporated on 20 July 2020 and lists its registered address as Boulder, United States. 5 shareholders are on record for EnLiven Therapeutics, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Colorado Secretary of State and was last updated on 18 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of EnLiven Therapeutics
Five shareholders are currently on record for EnLiven Therapeutics, reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 5.8% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund at 2.8%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 5.8% | Colorado Secretary of State | |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.8% | Colorado Secretary of State | |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 2.8% | Colorado Secretary of State | |
| Fidelity Select Portfolios-Select Health Care Portfolio | 2.6% | Colorado Secretary of State | |
| iShares Trust-iShares Russell 2000 ETF | 2.1% | Colorado Secretary of State |
Officers
7
Directors and officers of EnLiven Therapeutics
The Ceo, President & Director of EnLiven Therapeutics currently on record is Richard A. Fair; seven officers are currently on record for EnLiven Therapeutics, filed with Colorado Secretary of State. Management authority at EnLiven Therapeutics sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of EnLiven Therapeutics
EnLiven Therapeutics has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Enliven Inc. (United States)
Data availability
Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
EnLiven Therapeutics
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns EnLiven Therapeutics?
Five shareholders are currently on record for EnLiven Therapeutics, reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 5.8% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund at 2.8%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is EnLiven Therapeutics's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for EnLiven Therapeutics is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does EnLiven Therapeutics have on record?
5 shareholders are shown on record for EnLiven Therapeutics.
What is EnLiven Therapeutics's company registration number?
EnLiven Therapeutics's registration number is 20201617684, filed with Colorado Secretary of State in United States. Its current status on the register is active.
Is EnLiven Therapeutics still an active company?
EnLiven Therapeutics's status on Colorado Secretary of State is listed as active.
When was EnLiven Therapeutics incorporated?
EnLiven Therapeutics was incorporated on 20 July 2020, according to Colorado Secretary of State.
What is EnLiven Therapeutics's registered address?
The registered address on file for EnLiven Therapeutics is Boulder, United States.
Who are the officers/directors of EnLiven Therapeutics?
The Ceo, President & Director of EnLiven Therapeutics currently on record is Richard A. Fair; seven officers are currently on record for EnLiven Therapeutics, filed with Colorado Secretary of State. Management authority at EnLiven Therapeutics sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does EnLiven Therapeutics have a parent company or subsidiaries?
EnLiven Therapeutics has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to EnLiven Therapeutics's ownership over time?
This profile reflects a point-in-time snapshot from Colorado Secretary of State. Zavia's monitoring API can track changes to EnLiven Therapeutics's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access EnLiven Therapeutics's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like EnLiven Therapeutics's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Colorado Secretary of State and was last synced on 18 September 2026.